Mammographic, US, and MR imaging phenotypes of familial breast cancer

Radiology

Volumn 246, Issue 1, 2008, Pages 58-70

  Schrading, Simone ^a   Kuhl, Christiane K ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; MUTATION; PHENOTYPE; PROSPECTIVE STUDIES;

EID: 37349072456     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2461062173     Document Type: Article

References (40)

1. Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001;19:924-930.
2. Komenaka IK, Ditkoff BA, Joseph KA, et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100:2079-2083.
3. Lakhami SR, Jacquemier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998;90:1138-1145.
4. Lynch BJ, Holden JA, Buys SS, Neuhausen SL, Gaffney DK. Pathologic characteristics of hereditary breast cancer. Hum Pathol 1998;29:1140-1144.
5. Marcus JN, Watson P, Page DL, Lynch HT. Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr 1994;16:23-34.
6. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 1997;349:1505-1510.
7. Tilanus-Linthorst M, Verhoog L, Obdeijn IM, et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 2002;102:91-95. [Published correction appears in Int J Cancer 2002;102:665.]
8. Eisinger F, Nogues C, Birnbaum D, Jacquemier J, Sobol H. BRCA 1 and medullary breast cancer. JAMA 1998;280:1227-1228.
9. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19:3524-3531.
10. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, utrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-1325.
11. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MK imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215:267-279.
12. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high genetic risk for breast cancer. J Clin Oncol 2005;23:8469-8476.
13. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-437.
14. Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93:1095-1102.
15. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181:619-626.
16. American College of Radiology. Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Reston, Va: American College of Radiology, 2003.
17. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.
18. Kaas R, Kroger R, Hendriks JH, et al. The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. Eur Radiol 2004;14:1647-1053.
19. Lamb PM, Perry NM, Vinnicombe SJ, Wells CA. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol 2000;55:40-44.
20. Sickles EA. Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient. Radiology 1994;192:439-442.
21. Lalloo F, Evans DG. The pathology of familial breast cancer: clinical and genetic counselling implications of breast cancer pathology. Breast Cancer Res 1999;1:48-51.
22. Meyer JE, Amin E, Lindfors KK, Lipman JC, Stomper PC, Genest D. Medullary carcinoma of the breast: mammographic and US appearance. Radiology 1989;170:79-82.
23. Yilmaz E, Lebe B, Balci P, Sal S, Canda T. Comparison of mammographic and sonographic findings in typical and atypical medullary carcinomas of the breast. Clin Radiol 2002;57:640-645.
24. Lakhani SR, Gusterson BA, Jacquemier J, et al. The pathology of familial breast cancer: histological features of cancers in families not attributed to mutations in BRCA1 or BRCA2. Clin Cancer Res 2000;6:782-789.
25. Marcus JN, Watson P, Page DL, et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 1996;77:697-709.
26. Morgan MP, Cooke MM, McCarthy GM. Microcalcifications associated with breast cancer: an epiphenomenon or biologically significant feature of selected tumors? J Mammary Gland Biol Neoplasia 2005;10:181-187.
27. Barreau B, de Mascarel I, Feuga C, et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol 2005;54:55-61.
28. de Paredes ES, Abbitt PL, Tabbarah S, Bickers MA, Smith DC. Mammographic and histologic correlations of microcalcifications. RadioGraphics 1990;10:577-589.
29. Malone KE, Daling JR, Neal C, et al. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 2000;88:1393-1402.
30. Peto J, Collins N, Barfoot R, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999;91:943-949.
31. Helvie MA, Roubidoux MA, Weber BL, Merajver SD. Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA 1: initial experience. AJR Am J Roentgenol 1997;168:1599-1602.
32. Armes JE, Egan AJ, Southey MC, et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study. Cancer 1998;83:2335-2345.
33. Gilhuijs KG, Deurloo EE, Muller SH, Peterse JL, Schultze Kool LJ. Breast MR imaging in women at increased lifetime risk of breast cancer: clinical system for computerized assessment of breast lesions - initial results. Radiology 2002;225:907-916.
34. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997;203:137-144.
35. Müller-Schimpfle M, Ohmenhäuser K, Claussen CD. Effect of age and menstrual cycle on mammography and MR mammography [in German]. Radiologe 1997;37:718-725.
36. Kaiser WA. False-positive results in dynamic MR mammography: causes, frequency, and methods to avoid. Magn Reson Imaging Clin N Am 1994;2:539-555.
37. MacLachlan TK, Somasundaram K, Sgagias M, et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem 2000;275:2777-2785.
38. Somasundaram K. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair-perhaps through transcription. J Cell Biochem 2003;88:1084-1091.
39. Zhong Q, Chen CF, Li S, et al. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 1999;285:747-750.
40. Deng CX, Wang RH. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet 2003;12(Spec No. 1):R113-R123.